STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #1997 by analyst upside · 2026-08-13
GRDN
Guardian Pharmacy Services, Inc.
Healthcare · Market Cap $2B · P/E 37.1x
ANALYST PRICE TARGET
+26.6%
implied upside to consensus target
Current Price $38.58
Consensus Target $48.83
Bull Target $50.0
Bear Target $47.0
Analysts Covering 6
ANALYST CONSENSUS - BUY
Strong Buy
1
Buy
5
Hold
0
Sell
0
52-Week Low $22.1
52-Week High $47.02
YTD Return +30.6%
FUNDAMENTALS
Market Cap $2B
P/E Ratio (TTM) 37.1x
Forward P/E 27.0x
EPS (TTM) $1.04
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $1.5B
Profit Margin 4.5%
52-WEEK RANGE
52-Week Low $22.1
52-Week High $47.02
Current Price $38.58
Bear Target $47.0
Bull Target $50.0
● Now $38.58 ● Target $48.83
TRADING DATA
Avg Volume 410K
YTD Return +30.6%
Analyst Count 6
Consensus Buy
Upside to Target +26.6%
Last Updated 2026-08-13

ANALYST SUMMARY

Guardian Pharmacy Services, Inc. (GRDN) is currently trading at $38.58 with a Wall Street consensus price target of $48.83, implying potential upside of 26.6% over the next 12 months. 6 analysts currently cover GRDN, with a consensus rating of Buy - 100% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $50.0, while the most cautious has a target of $47.0.

GRDN operates in the Healthcare sector with a market capitalisation of $2B. The stock is up 30.6% year-to-date and is currently trading near the upper end of its 52-week range of $22.1 – $47.02.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for GRDN, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Truist Securities - Reiterated
Buy → Buy 2026-06-17 Building track record
B of A Securities - Reiterated
Buy → Buy 2026-06-17 Building track record
Oppenheimer - Reiterated
Outperform → Outperform 2026-05-07 14% win rate (7 calls)
B of A Securities ● Initiated
Buy 2026-04-27 Building track record
Truist Securities - Reiterated
Buy → Buy 2026-04-13 Building track record
Jefferies ● Initiated
Buy 2026-03-30 50% win rate (6 calls)
Oppenheimer - Reiterated
Outperform → Outperform 2026-03-12 14% win rate (7 calls)
Truist Securities - Reiterated
Buy → Buy 2026-03-12 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
70
out of 100
Coverage depth
15/30
Consensus clarity
28/30
Vote unanimity
25/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →